SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $341,000 | +21.4% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $281,000 | -12.5% | 2,000 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $321,000 | +24.4% | 2,000 | 0.0% | 0.01% | +75.0% |
| Q4 2019 | $258,000 | +14.2% | 2,000 | -33.3% | 0.00% | +33.3% |
| Q3 2019 | $226,000 | -96.7% | 3,000 | -93.3% | 0.00% | -96.6% |
| Q2 2019 | $6,814,000 | -34.8% | 44,845 | -48.8% | 0.09% | -36.7% |
| Q1 2019 | $10,448,000 | +75.7% | 87,655 | +60.8% | 0.14% | +56.2% |
| Q4 2018 | $5,948,000 | -43.2% | 54,505 | -15.9% | 0.09% | -32.6% |
| Q3 2018 | $10,463,000 | +155.6% | 64,785 | +109.2% | 0.13% | +153.8% |
| Q2 2018 | $4,094,000 | +83.8% | 30,975 | +3.0% | 0.05% | +85.7% |
| Q1 2018 | $2,228,000 | +35.4% | 30,075 | +1.7% | 0.03% | +47.4% |
| Q4 2017 | $1,646,000 | +1632.6% | 29,575 | +824.2% | 0.02% | +1800.0% |
| Q2 2014 | $95,000 | -74.0% | 3,200 | -78.9% | 0.00% | -80.0% |
| Q1 2014 | $365,000 | +15.5% | 15,200 | -1.9% | 0.01% | +25.0% |
| Q4 2013 | $316,000 | -53.2% | 15,500 | +8.4% | 0.00% | -50.0% |
| Q3 2013 | $675,000 | -6.4% | 14,300 | -24.5% | 0.01% | -20.0% |
| Q2 2013 | $721,000 | – | 18,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |